open access

Vol 6 (2021): Continuous Publishing
Case report
Published online: 2021-07-15
Get Citation

An improved vision after treatment of endophthalmitis following keratoprosthesis — a report of two cases

Farheen Fatima1, Amna Anwar2, Farah Naz3, Azam Ali1
·
Ophthalmol J 2021;6:61-64.
Affiliations
  1. Section of Ophthalmology, Department of Surgery, Aga Khan University Hospital, Stadium Road, Karachi, Pakistan
  2. Jinnah Medical College Hospital, Karachi, Pakistan
  3. Dha Suffa University, DHA, Karachi, Pakistan

open access

Vol 6 (2021): Continuous Publishing
CASE REPORTS
Published online: 2021-07-15

Abstract

Endophthalmitis following keratoprosthesis could lead to permanent loss of vision and the eye. It needs systematic
management and close follow-ups as the outcome is unpredictable.

We present two cases of endophthalmitis following type I Boston keratoprosthesis (KPro). Both of our patients had
lost one eye while the other eye developed endophthalmitis after they underwent prosthokeratoplasty. They were
aggressively treated with topical and oral antibiotics with close follow-ups. Vitreous cultures were obtained, and
intravitreal antibiotics were given. The endophthalmitis resolved with a dramatically improved vision.

Abstract

Endophthalmitis following keratoprosthesis could lead to permanent loss of vision and the eye. It needs systematic
management and close follow-ups as the outcome is unpredictable.

We present two cases of endophthalmitis following type I Boston keratoprosthesis (KPro). Both of our patients had
lost one eye while the other eye developed endophthalmitis after they underwent prosthokeratoplasty. They were
aggressively treated with topical and oral antibiotics with close follow-ups. Vitreous cultures were obtained, and
intravitreal antibiotics were given. The endophthalmitis resolved with a dramatically improved vision.

Get Citation

Keywords

keratoprosthesis (KPro); endophthalmitis

About this article
Title

An improved vision after treatment of endophthalmitis following keratoprosthesis — a report of two cases

Journal

Ophthalmology Journal

Issue

Vol 6 (2021): Continuous Publishing

Article type

Case report

Pages

61-64

Published online

2021-07-15

Page views

6016

Article views/downloads

391

DOI

10.5603/OJ.2021.0012

Bibliographic record

Ophthalmol J 2021;6:61-64.

Keywords

keratoprosthesis (KPro)
endophthalmitis

Authors

Farheen Fatima
Amna Anwar
Farah Naz
Azam Ali

References (10)
  1. Pineda R. The Boston keratoprosthesis in Stevens-Johnson syndrome. Evidence-Based Ophthalmol. 2008; 9(3): 166–167.
  2. Ciralsky J, Papaliodis GN, Foster S, et al. Keratoprosthesis in autoimmune disease. Ocul Immunol Inflamm. 2010; 18(4): 275–280.
  3. Tuft SJ, Shortt AJ. Surgical rehabilitation following severe ocular burns. Eye (Lond). 2009; 23(10): 1966–1971.
  4. Harissi-Dagher M, Dohlman CH. The Boston Keratoprosthesis in severe ocular trauma. Can J Ophthalmol. 2008; 43(2): 165–169.
  5. Chew HF, Ayres BD, Hammersmith KM, et al. Boston keratoprosthesis outcomes and complications. Cornea. 2009; 28(9): 989–996.
  6. Bradley J, Hernandez E, Schwab I, et al. Boston Type 1 Keratoprosthesis: The University of California Davis Experience. Cornea. 2009; 28(3): 321–327.
  7. Aldave A, Kamal K, Vo R, et al. The Boston Type I Keratoprosthesis. Ophthalmology. 2009; 116(4): 640–651.
  8. Akpek EK, Harissi-Dagher M, Petrarca R, et al. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. Am J Ophthalmol. 2007; 144(2): 227–231.
  9. Durand ML, Dohlman CH. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea. 2009; 28(8): 896–901.
  10. Georgalas I, Kanelopoulos AJ, Petrou P, et al. Presumed endophthalmitis following Boston keratoprosthesis treated with 25 gauge vitrectomy: a report of three cases. Graefes Arch Clin Exp Ophthalmol. 2010 ; 248(3): 447–450.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Publisher: VM Media Group sp. z o.o., Grupa Via Medica, 73 Świętokrzyska St., 80–180 Gdańsk

tel.:+48 58 310 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl